AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 109 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $32,000 | -25.6% | 51,000 | 0.0% | 0.02% | -46.2% |
Q3 2019 | $43,000 | +26.5% | 51,000 | 0.0% | 0.04% | +25.8% |
Q2 2019 | $34,000 | -19.0% | 51,000 | 0.0% | 0.03% | -22.5% |
Q1 2019 | $42,000 | +133.3% | 51,000 | +363.6% | 0.04% | +122.2% |
Q4 2018 | $18,000 | -50.0% | 11,000 | 0.0% | 0.02% | -41.9% |
Q3 2018 | $36,000 | +44.0% | 11,000 | 0.0% | 0.03% | +55.0% |
Q2 2018 | $25,000 | -21.9% | 11,000 | 0.0% | 0.02% | -23.1% |
Q1 2018 | $32,000 | +3.2% | 11,000 | 0.0% | 0.03% | 0.0% |
Q4 2017 | $31,000 | -22.5% | 11,000 | 0.0% | 0.03% | -23.5% |
Q3 2017 | $40,000 | – | 11,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |